• 1. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Introduction to 2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine (CAS No. 1824318-20-8)

2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine, identified by the CAS number 1824318-20-8, is a specialized heterocyclic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to the pyridine family, which is well-documented for its diverse biological activities and industrial applications. The structural features of this molecule, including its chloro, iodo, and trifluoromethyl substituents, make it a valuable intermediate in the synthesis of various pharmacologically active agents.

The presence of multiple halogen atoms and a trifluoromethyl group in 2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine enhances its reactivity and functionalizability, making it a versatile building block for medicinal chemists. In recent years, there has been a surge in research focused on developing novel compounds with enhanced efficacy and reduced side effects. This compound has emerged as a key intermediate in the synthesis of kinase inhibitors, anticancer agents, and antimicrobial drugs.

One of the most compelling aspects of 2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine is its role in the development of targeted therapies. The pyridine core is a common scaffold in many drugs due to its ability to interact with biological targets such as enzymes and receptors. The halogenated substituents further modulate the electronic properties of the molecule, allowing for precise tuning of its biological activity. For instance, studies have shown that compounds derived from this scaffold exhibit potent inhibitory effects against various kinases, which are crucial targets in oncology research.

Recent advancements in synthetic methodologies have enabled the efficient preparation of 2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine, making it more accessible for industrial applications. Researchers have employed palladium-catalyzed cross-coupling reactions to introduce additional functional groups onto the pyridine ring, expanding the library of derivatives with potential therapeutic value. These synthetic strategies have not only improved yield but also reduced the environmental impact of the manufacturing process.

The trifluoromethyl group is particularly noteworthy due to its ability to enhance metabolic stability and binding affinity. This substituent is frequently incorporated into drug candidates to improve their pharmacokinetic properties. In particular, trifluoromethyl compounds have shown promise in treating inflammatory diseases and infectious disorders. The iodo atom serves as a handle for further functionalization via nucleophilic aromatic substitution or metal-catalyzed coupling reactions, providing multiple pathways for derivatization.

In the realm of agrochemicals, 2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine has been explored as a precursor for developing novel pesticides and herbicides. The structural motifs present in this compound contribute to its bioactivity against pests while maintaining environmental safety. Researchers are increasingly focusing on green chemistry principles to minimize the ecological footprint of agrochemicals, and compounds like this one align well with these objectives.

The compound's versatility also extends to material science applications. Pyridine derivatives are known for their role in designing advanced materials such as organic semiconductors and liquid crystals. The electron-withdrawing nature of the chloro and trifluoromethyl groups can influence electronic properties, making this compound a candidate for optoelectronic devices.

Looking ahead, the future prospects for 2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine are promising. Ongoing research aims to uncover new synthetic routes and explore its potential in drug discovery pipelines. Collaborative efforts between academia and industry are expected to accelerate the development of next-generation therapeutics based on this scaffold. As computational chemistry techniques advance, virtual screening methods will be employed to identify novel derivatives with optimized properties.

In conclusion, 2,3-Dichloro-4-iodo-6-(trifluoromethyl)pyridine (CAS No. 1824318-20-8) represents a cornerstone in modern chemical synthesis and drug development. Its unique structural features offer unparalleled opportunities for creating innovative compounds with significant therapeutic and industrial applications. As research continues to evolve, this compound will undoubtedly play an integral role in shaping the future of pharmaceuticals and agrochemicals.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)